drugset / Trial / NCT01956786
Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine
Phase 2/3
Unknown
540 enrolled
Shenzhen Ausa Pharmed Co.,Ltd
Ruijin Hospital · collabSecond Affiliated Hospital of Nanchang University · collabXuzhou Medical University · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the efficacy of Amlodipine-Folic Acid Tablets on reduction of blood pressure and plasma total homocysteine.
Timeline
- Start
- 2013-09
- Primary completion
- 2013-12
- Completion
- 2014-02
Outcome
Met primary endpoint
paper B group also had a higher rate of lowering both tHcy and BP (20.3% vs. 6.0%; OR: 5.90; 95% CI, 2.11-16.47, P < .001). PMID 37433173 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | — |
| Subject | folic acid | Other / unclassified | 0.4 mg | — |
| Subject | folic acid | Other / unclassified | 0.8 mg | — |